We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTX icon
401
MarketAxess Holdings
MKTX
$5.72B
$40.9M 0.04%
146,535
+7,035
+5% +$1.81M
PII icon
402
Polaris
PII
$3.97B
$40.7M 0.04%
402,706
+2,862
+0.7% +$298K
AMG icon
403
Affiliated Managers Group
AMG
$9.6B
$40.2M 0.04%
253,474
+95,362
+60% +$13.5M
HIG icon
404
Hartford Financial Services
HIG
$38.7B
$40.1M 0.04%
528,777
+79,639
+18% +$5.73M
BR icon
405
Broadridge
BR
$19.8B
$39.7M 0.04%
296,329
-375
-0.1% -$53.3K
PRU icon
406
Prudential Financial
PRU
$42.1B
$39.6M 0.04%
398,483
+12,361
+3% +$1.25M
FICO icon
407
Fair Isaac
FICO
$22.7B
$38.9M 0.04%
64,978
+798
+1% +$420K
KR icon
408
Kroger
KR
$34.6B
$38.9M 0.04%
871,473
+11,345
+1% +$521K
VFH icon
409
Vanguard Financials ETF
VFH
$13.8B
$38.7M 0.04%
468,289
+27,692
+6% +$2.29M
MASI
410
DELISTED
Masimo
MASI
$38.7M 0.04%
261,745
-21,283
-8% -$2.93M
LULU icon
411
lululemon athletica
LULU
$14.5B
$38.6M 0.04%
120,412
-166
-0.1% -$54.6K
KDP icon
412
Keurig Dr Pepper
KDP
$39.9B
$38.6M 0.04%
1,081,271
+29,990
+3% +$1.12M
CLVT icon
413
Clarivate
CLVT
$1.21B
$38.5M 0.04%
4,614,020
+1,864,656
+68% +$17.5M
IYG icon
414
iShares US Financial Services ETF
IYG
$2.21B
$38.2M 0.04%
727,515
-24,231
-3% -$1.27M
BUD icon
415
AB InBev
BUD
$164B
$38.1M 0.04%
634,251
-207
-0% -$11.1K
SGOV icon
416
iShares 0-3 Month Treasury Bond ETF
SGOV
$101B
$38M 0.03%
379,091
+349,773
+1,193% +$35M
BCS icon
417
Barclays
BCS
$94.2B
$37.8M 0.03%
4,841,884
+119,412
+3% +$871K
FAST icon
418
Fastenal
FAST
$59.8B
$37.5M 0.03%
1,583,642
-94,316
-6% -$2.31M
ROST icon
419
Ross Stores
ROST
$81.7B
$37.4M 0.03%
321,946
-21,348
-6% -$2.18M
JEPI icon
420
JPMorgan Equity Premium Income ETF
JEPI
$46B
$37.3M 0.03%
683,669
-54,691
-7% -$2.97M
VHT icon
421
Vanguard Health Care ETF
VHT
$19B
$37M 0.03%
149,027
-7,319
-5% -$1.77M
LYB icon
422
LyondellBasell Industries
LYB
$20.2B
$36.9M 0.03%
444,844
+272,106
+158% +$22.3M
GSK icon
423
GSK
GSK
$104B
$36.8M 0.03%
1,048,232
-25,928
-2% -$864K
IT icon
424
Gartner
IT
$12.2B
$36.8M 0.03%
109,410
-19,561
-15% -$6.31M
EEM icon
425
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$36.6M 0.03%
966,278
+82,436
+9% +$3.04M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.